Evidence map›Paper›PMID 37646039›Full record

ReviewFrontiers in immunology2023

Research progress of extracellular vesicles and exosomes derived from mesenchymal stem cells in the treatment of oxidative stress-related diseases.

Wenwen Zhang, Tingyu Wang, Yuanye Xue, Bingbing Zhan, Zengjie Lai, Wenjie Huang, Xinsheng Peng, Yanfang Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. From Genome to Geroscience: How DNA Damage Shapes Systemic Decline.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Wenwen ZhangThe First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China.
Tingyu WangThe First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China.
Yuanye XueThe First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China.
Bingbing ZhanSchool of Pharmaceutical Sciences, Guangdong Medical University, Dongguan, China.
Zengjie LaiThe Second Clinical Medical College of Guangdong Medical University, Dongguan, China.
Wenjie HuangSchool of Medical Technology, Guangdong Medical University, Dongguan, China.
Xinsheng PengBiomedical Innovation Center, Guangdong Medical University, Dongguan, China.
Yanfang ZhouThe First Dongguan Affiliated Hospital of Guangdong Medical University, Dongguan, Guangdong, China.
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing evidence that mesenchymal stem cell-derived extracellular vesicles and exosomes can significantly improve the curative effect of oxidative stress-related diseases. Mesenchymal stem cell extracellular vesicles and exosomes (MSC-EVs and MSC-Exos) are rich in bioactive molecules and have many biological regulatory functions. In this review, we describe how MSC-EVs and MSC-Exos reduce the related markers of oxidative stress and inflammation in various systemic diseases, and the molecular mechanism of MSC-EVs and MSC-Exos in treating apoptosis and vascular injury induced by oxidative stress. The results of a large number of experimental studies have shown that both local and systemic administration can effectively inhibit the oxidative stress response in diseases and promote the survival and regeneration of damaged parenchymal cells. The mRNA and miRNAs in MSC-EVs and MSC-Exos are the most important bioactive molecules in disease treatment, which can inhibit the apoptosis, necrosis and oxidative stress of lung, heart, kidney, liver, bone, skin and other cells, and promote their survive and regenerate.

Indexed as

ExosomesExtracellular VesiclesMesenchymal Stem CellsAdministration, CutaneousOxidative Stresscell proliferationexosomesextracellular vesiclesinflammationmesenchymal stem cellsoxidative stress

Identifiers

PMID37646039
PMCPMC10461809
OpenAlexW4385840038

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.